Clinical Trials on Adrenal Malignancies in United Kingdom
Total 6722 results
-
AstraZenecaQuintiles, Inc.CompletedSolid MalignanciesUnited Kingdom
-
MEI Pharma, Inc.Quotient ClinicalCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Memorial Sloan Kettering Cancer CenterCompletedAdrenal Tumors | Adrenal Malignancies | Abnormal Hormonal Secretions | Electrolytes AbnormalitiesUnited States
-
University College, LondonCompletedCD19+ Malignancies: Relapse Post-allogeneic TransplantUnited Kingdom
-
University Hospital Plymouth NHS TrustCompletedLiver Cirrhosis | Acute Kidney Injury | Hepato-Renal SyndromeUnited Kingdom
-
Gilead SciencesActive, not recruitingB-cell MalignanciesUnited States, United Kingdom, France
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid MalignanciesUnited States, United Kingdom, Canada, Korea, Republic of
-
University College, LondonUniversity College London Hospitals; Cambridge University Hospitals NHS Foundation... and other collaboratorsCompletedPrimary Hyperaldosteronism | Primary Hyperaldosteronism Due to Adrenal AdenomaUnited Kingdom
-
Imperial College LondonRecruiting
-
Imperial College LondonNational Institute for Health Research, United Kingdom; Imperial Health CharityActive, not recruitingAdrenal InsufficiencyUnited Kingdom
-
Imperial College LondonNational Institute for Health Research, United KingdomUnknownAdrenal InsufficiencyUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
King's College Hospital NHS TrustActive, not recruitingAdrenocortical CarcinomaUnited Kingdom
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplant | Haematological Malignancies | CD56+CD3- NK CellsUnited Kingdom
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Gilead SciencesCompletedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Diurnal LimitedSimbec Research; Brush Clinical Research Ltd.; Voet Consulting; Bionical Emas Ltd. and other collaboratorsCompletedAdrenal InsufficiencyUnited Kingdom
-
Diurnal LimitedSimbec Research; EMAS Pharma; Brush Clinical Research Ltd.; Voet Consulting; Medical...CompletedAdrenal InsufficiencyUnited Kingdom
-
Diurnal LimitedSimbec ResearchCompleted
-
Diurnal LimitedSimbec Research; Brush Clinical Research Ltd.; Voet Consulting; Medical Matters... and other collaboratorsCompletedAdrenal InsufficiencyUnited Kingdom
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
CelgeneActive, not recruitingNeoplasms | Hematologic Malignancies | Hematologic NeoplasmUnited Kingdom, United States
-
Royal Cornwall Hospitals TrustCompletedPalliative Care | Hematologic Malignancy | Oncology | End Stage CancerUnited Kingdom
-
Kiromic, Inc.TerminatedCancer | Progressive Solid Malignancies | Refractory Solid MalignanciesUnited States
-
BeiGeneCompletedB-cell MalignanciesUnited States, Korea, Republic of, Australia, New Zealand, United Kingdom, Italy
-
University College, LondonMedical Research CouncilCompletedHaematological MalignanciesUnited Kingdom
-
Nottingham University Hospitals NHS TrustNewcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...TerminatedCancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological MalignancyUnited Kingdom
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
The Christie NHS Foundation TrustRecruitingCOVID | Oncology | Haematological MalignancyUnited Kingdom
-
The London ClinicRecruitingAddison's DiseaseUnited Kingdom
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
Newcastle UniversityCompleted
-
Sheffield Children's NHS Foundation TrustCompletedAdrenal InsufficiencyUnited Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
Imperial College LondonUniversity of Nottingham; Nottingham University Hospitals NHS Trust; NHS Blood... and other collaboratorsCompletedAutoimmune Diseases | Haematological Malignancies | Solid Organ Transplant RecipientsUnited Kingdom
-
AdaptimmuneRecruitingSolid and Hematological MalignanciesUnited States, Spain, Canada, United Kingdom
-
Manchester University NHS Foundation TrustRecruitingAdrenal Hyperplasia, CongenitalUnited Kingdom
-
AgennixTerminatedMalignanciesUnited States